Merck Opens Vaccine Manufacturing Facility in North Carolina
Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats. Drugmakers have been exploring the possibility of government-granted exemptions for domestically manufactured medicines since Trump has threatened to impose 25% tariff on pharmaceutical imports.
In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, ...
With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.
Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...
The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...
Achieves ISO9001, EFfCI GMP, and EXCiPACT certifications for its new manufacturing plant.
Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...
The factory was manufacturing the suspected culprit ... help them determine the cause of the deaths. Kobayashi Pharmaceutical also has a plant in Wakayama Prefecture where the benikoji ...
With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...
ABUJA, NIGERIA / ACCESS Newswire / March 11, 2025 / In a landmark effort to transform Nigeria's pharmaceutical industry and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback